STOCK TITAN
  1. Home
  2. News
  3. PKI

PerkinElmer to Present at J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer Inc., (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 at 8:15 a.m. PT.

Prahlad Singh, president and chief executive officer, will provide an update on the Company and its strategic priorities.

To access the presentation, a live audio webcast will be available via this page. A replay of the presentation will be posted on the PerkinElmer Investor Relations website after the event and will be available for at least 30 days.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $5 billion in 2021, has more than 16,000 employees serving customers in 190 countries, and is a component of the S&P 500 Index. Additional information is available at www.perkinelmer.com.

Investor Relations:

Steve Willoughby

(781) 663-5677

steve.willoughby@perkinelmer.com

Media Relations:

Chet Murray

(781) 663-5719

chet.murray@perkinelmer.com

Source: PerkinElmer Inc.

Stock PKI logo
Revvity Inc.

NYSE:PKI

PKI Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

PKI Latest News

Apr 25, 2024
Revvity Board Declares Quarterly Dividend
Apr 25, 2024
Revvity to Present at BofA Securities 2024 Health Care Conference
Apr 24, 2024
Revvity Unveils a New Era of Automated Tuberculosis Testing
Apr 15, 2024
Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners
Apr 4, 2024
Revvity To Hold Earnings Call on Monday, April 29, 2024

PKI Stock Data

Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
Health Technology, Medical Specialties, Manufacturing, Analytical Laboratory Instrument Manufacturing
US
Boston

About PKI

PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to serve the diagnostics, life sciences, food, and applied markets. IT strategically partners with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Its dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.